superDimension launches the iLogic electromagnetic navigation bronchoscopy tool

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today the launch of the iLogic System for early lung cancer detection and diagnosis. The device is the second generation version of inReach(TM), superDimension's electromagnetic navigation bronchoscopy (ENB) minimally invasive tool. The core technology for both inReach and iLogic extend beyond the capabilities of the traditional bronchoscope to distant, previously inaccessible regions of the lungs, and enables physicians to locate small lung lesions for diagnostic testing. superDimension debuted the iLogic(TM) system at the American College of Chest Physicians (CHEST) annual meeting in San Diego and the American Society for Radiation Oncology (ASTRO) Conference in Chicago.

Improvements offered by the iLogic include a new software platform with a simplified positioning and navigational system that improves ease of use and further enhances visualization for the pulmonologist. The virtual 3-D bronchial tree made possible with the technology extends deep into the lungs reaching more than 17 airway generations. Further, the customized high-definition views available with iLogic offer physicians multiple navigation perspectives to improve detection and diagnosis. A 26-inch high-definition wide screen format allows six viewports to be displayed simultaneously, including one video input, enabling the physician to evaluate positional data and optimize central and peripheral guidance within the lung.

"We believe the more elegant and simplified iLogic software will surpass the needs of the pulmonologists who find inReach invaluable for the treatment of their patients," said Daniel J. Sullivan, president and Chief Executive Officer. "As medical professionals become more comfortable and familiar with ENB, we believe the introduction of iLogic will further ignite enthusiasm for adoption of the system and ultimately, improve patient outcomes."

superDimension is exhibiting at the American College of Chest Physicians (CHEST) annual meeting in San Diego at booth 819 and the American Society for Radiation Oncology (ASTRO) Conference in Chicago at booth 3216.

Source:

superDimension, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients